- Home
- / Relay Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Relay Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$5.9
2024-10-29
Market Capitalization
$958.5 M
2024-10-29
Revenue
$15.4 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|
| Revenue | 82.7M | 30.3M | 1.4M | 25.5M | 10.0M | 15.4M |
| General and administrative expense | 38.6M | 57.4M | 66.0M | 75.0M | 76.6M | 56.7M |
| Operating expense total | 138.5M | 230.0M | 312.3M | 405.0M | 395.7M | 318.1M |
| EBIT | (55.8M) | (364.7M) | (299.3M) | (373.0M) | (372.5M) | (302.7M) |
| EBIT margin, % | -67.5% | -1204.0% | -21670.9% | -1460.1% | -3722.1% | -1971.6% |
| Interest income | 3.4M | 830.0K | 8.8M | 31.0M | 34.7M | 27.0M |
| Net Income | (52.4M) | (363.9M) | (290.5M) | (342.0M) | (337.7M) | (276.5M) |
| EPS | (2.6) | (2.8) | (2.4) | (1.6) |